Camino Real Capital Partners

Camino Real Capital Partners, LLC is a private equity and venture capital firm located in Santa Fe, New Mexico. The firm specializes in strategic acquisitions, targeting innovators and emerging technologies, particularly in transformative technology, medical devices, life sciences, and energy sector services. It focuses on companies that have limited access to private investment, typically investing between $0.25 million and $10 million in transactions valued from $0.5 million to $50 million. Camino Real Capital Partners primarily considers investment opportunities within the United States, including New Mexico.

Thomas Nickoloff

Founder and Managing Principal

3 past transactions

Autonomic Materials

Venture Round in 2022
Autonomic Materials, Inc. is a company based in Champaign, Illinois, specializing in self-healing solutions for the coatings industry. Founded in 2005, it designs and manufactures microencapsulated additives that enhance the performance of coatings, adhesives, and sealants. These additives include dual capsule systems utilizing reactive silicone polymers, single capsule systems for epoxy resin curing, and formulations based on oxygen-initiated cross-linking of alkyd resins. The company’s products provide corrosion protection and enable automatic repair of coating damage at the micron level, making them suitable for diverse applications including automotive, military equipment, infrastructure, and consumer paints. By responding to damage as it occurs, Autonomic Materials helps extend the lifespan and performance of various substrates such as metals, wood, concrete, and plastics, thereby serving industries like alternative energy, industrial maintenance, and oil and gas.

Broadspot Imaging

Series A in 2018
BroadSpot Imaging Corporation focuses on developing diagnostic medical devices for eye care, specifically in the area of retinal imaging. The company employs advanced imaging technologies and compact, cloud-connected electronics to create cost-effective handheld instruments that replace traditional bulky and expensive diagnostic tools. By integrating AI and machine learning applications, BroadSpot Imaging aims to enhance the efficiency and accessibility of eye care services. Their innovations are designed to meet the growing demand for high-quality diagnostics, particularly as the population ages, allowing eye care professionals to serve more patients effectively and affordably across various medical settings.

Broadspot Imaging

Series A in 2017
BroadSpot Imaging Corporation focuses on developing diagnostic medical devices for eye care, specifically in the area of retinal imaging. The company employs advanced imaging technologies and compact, cloud-connected electronics to create cost-effective handheld instruments that replace traditional bulky and expensive diagnostic tools. By integrating AI and machine learning applications, BroadSpot Imaging aims to enhance the efficiency and accessibility of eye care services. Their innovations are designed to meet the growing demand for high-quality diagnostics, particularly as the population ages, allowing eye care professionals to serve more patients effectively and affordably across various medical settings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.